Form 4 Tracker
Edwards Lifesciences Corp
EW

62 insider filings · Latest: Oct 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 30, 2026Jul 1 12:01 AMDaniel J. LippisCVP, TAVR
Sale
619$91.40$56.6K40,410.91(D)

View →

Jun 17, 2026Jun 18 12:19 AMBernard J ZovighianDirector, CEO
Sale
523$87.92$46.0K11,516.551(I)

View →

May 29, 2026May 29 8:44 PMAndrew M. DahlSVP, Corporate Controller
Sale
567.527$86.08$48.9K15,334.095(D)

View →

May 29, 2026May 29 8:23 PMUllem Scott B.
Proposed Sale
64,152$86.59$5.6M—

View →

May 29, 2026May 29 8:12 PMDahl Andrew M.
Proposed Sale
568$86.01$48.9K—

View →

May 27, 2026May 27 11:28 PMDonald E Bobo JRCVP,Strategy/Corp Development
Sale
23,145$86.42$2.0M98,611(I)

View →

May 27, 2026May 27 8:19 PMBOBO JR FAMILY TRUST
Proposed Sale
23,145$86.42$2.0M—

View →

May 22, 2026May 22 8:35 PMDaveen ChopraCVP, TMTT & Surgical
Sale
1,500$84.60$126.9K44,324(D)

View →

May 22, 2026May 22 8:01 PMChopra Daveen
Proposed Sale
1,500$84.60$126.9K—

View →

May 18, 2026May 18 9:29 PMDaniel J. LippisCVP, TAVR
Sale
620$81.14$50.3K40,410.91(D)

View →

May 15, 2026May 18 9:28 PMDonald E Bobo JRCVP,Strategy/Corp Development
Sale
17,968$81.96$1.5M30,969.576(I)

View →

May 18, 2026May 18 8:10 PMLippis Daniel J.
Proposed Sale
1,858$81.14$150.8K—

View →

May 15, 2026May 15 8:04 PMBOBO DONALD E JR
Proposed Sale
9,968$82.07$818.1K—

View →

May 12, 2026May 12 8:55 PMBernard J ZovighianDirector, CEO
Sale
36,351$77.93$2.8M12,039.551(I)

View →

May 12, 2026May 12 8:02 PMZovighian Bernard J
Proposed Sale
36,874$77.93$2.9M—

View →

May 11, 2026May 12 1:33 AMWayne MarkowitzCVP, JAPAC
Sale
593$79.73$47.3K21,679.871(D)

View →

May 11, 2026May 11 8:10 PMMarkowitz Wayne
Proposed Sale
593$79.73$47.3K—

View →

May 4, 2026May 4 11:30 PMDaniel J. LippisCVP, TAVR
Sale
1,019$83.98$85.6K33,681.91(D)

View →

May 1, 2026May 4 11:30 PMDaniel J. LippisCVP, TAVR
Sale
1,019$83.01$84.6K33,933.91(D)

View →

May 4, 2026May 4 8:32 PMLippis Daniel J.
Proposed Sale
1,019$83.98$85.6K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 5, 2026May 5 11:08 PMScott B. UllemCVP, Chief Financial Officer
Option Exercise
13,000$59.260(D)

View →

May 4, 2026May 4 11:30 PMDaniel J. LippisCVP, TAVR
Option Exercise
1,019$59.260(D)

View →

May 1, 2026May 4 11:30 PMDaniel J. LippisCVP, TAVR
Option Exercise
1,019$59.261,019(D)

View →

Apr 9, 2026Apr 9 11:34 PMScott B. UllemCVP, Chief Financial Officer
Option Exercise
13,000$59.2613,000(D)

View →

Apr 6, 2026Apr 7 12:42 AMDaniel J. LippisCVP, TAVR
Option Exercise
1,019$59.262,038(D)

View →

Apr 2, 2026Apr 2 9:13 PMDonald E Bobo JRCVP,Strategy/Corp Development
Option Exercise
22,680$59.260(D)

View →

Mar 11, 2026Mar 11 9:15 PMScott B. UllemCVP, Chief Financial Officer
Option Exercise
13,000$59.2626,000(D)

View →

Mar 11, 2026Mar 11 9:10 PMDaniel J. LippisCVP, TAVR
Option Exercise
1,019$59.263,057(D)

View →

Mar 2, 2026Mar 2 10:50 PMDonald E Bobo JRCVP,Strategy/Corp Development
Option Exercise
11,340$59.2622,680(D)

View →

Feb 12, 2026Feb 13 10:37 PMBernard J ZovighianDirector, CEO
Option Exercise
25,350$59.260(D)

View →

← Previous

Page 2 of 2